Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Finally closed above $13 that seems to have been resistance, next stop $15?
Thanks….good volume today sold a few more at 13.85 still have a nice position there are rumors of news next week but who knows. XON doing well also.
ZIOP over 13 with decent volume thanks to Bill Miller's recommendation on CNBC yesterday.
101 Reasons To Own Ziopharm Oncology (ZIOP)
This 101 Reasons list has been compiled to bring investors' attention to a particular company in the immuno-oncology space: Ziopharm Oncology and it trades on the Nasdaq under the ticker symbol: ZIOP. We believe that when investors, both current and future, read through this list, they will come to appreciate the opportunity that this company represents.
http://seekingalpha.com/instablog/6566781-options2wealth/4175505-101-reasons-to-own-ziopharm-oncology-ziop
Why does short interest keep climbing? (LINK)
Why Does ZIOP Short Interest Keep Climbing?
Had to be that Lewis was out and Cooper was in. No other reason at this point. Jmho
Had to be that Lewis was out and Cooper was in. No other reason at this point. Jmho
We haven't learned why the company canceled two important presentations last month yet? Still going side lines.....
Time for a latte?
ZIOP still going with good volume…..sold just a few here at 11.85. Holding a position long term.
OMg, girlfriend. So happy, boom boom ZIOP
kABOOM! ZIOP a house of fire!
Hit $10.50 :D ZIOP
You could use the sleep ms sleeping beauty :p
Wake me up if hit $ 11 :p
Almost buy $10k worth, guts say nahh ~ wheuw
Looks like ZIOP needs a tampooon today
$ZIOP recent news/filings
bullish
## source: finance.yahoo.com
Mon, 08 Jun 2015 16:43:30 GMT ~ ZIOPHARM ONCOLOGY INC Files SEC form 8-K/A, Entry into a Material Definitive Agreement, Financial Statements and Exhi
read full: http://biz.yahoo.com/e/150608/ziop8-k_a.html
*********************************************************
Fri, 05 Jun 2015 12:44:12 GMT ~ Intrexon Announces Distribution Ratio for Distribution of ZIOPHARM Shares
[at noodls] - GERMANTOWN, Md., June 5, 2015 /PRNewswire/ -- Intrexon Corporation ('Intrexon') (NYSE: XON), a leader in synthetic biology, today announced that it has determined the final distribution ratio relating ...
read full: http://www.noodls.com/view/992CD7EF8E4C243C24607989AC2EC87C30281FB0
*********************************************************
Fri, 05 Jun 2015 12:00:00 GMT ~ Intrexon Announces Distribution Ratio for Distribution of ZIOPHARM Shares
[PR Newswire] - GERMANTOWN, Md., June 5, 2015 /PRNewswire/ -- Intrexon Corporation ("Intrexon") (XON), a leader in synthetic biology, today announced that it has determined the final distribution ratio relating to its previously announced distribution of all of its 17,830,305 shares of ZIOPHARM Oncology, Inc. ("ZIOPHARM") (ZIOP) common stock on or about June 12, 2015, the distribution date, as a pro rata dividend on shares of Intrexon common stock, and on warrants to purchase shares of Intrexon common stock ("Warrants"), outstanding on June 4, 2015, the record date. Based on the number of Intrexon shares outstanding and shares deliverable under Warrants as of the record date, holders of Intrexon common stock will receive 0.162203 shares of ZIOPHARM common stock in the distribution with respect to each outstanding share of Intrexon common stock they own at the close of business on the record date, and holders of Warrants will receive 0.162203 shares of ZIOPHARM common stock in the distribution with respect to each share of Intrexon common stock deliverable under the Warrants they hold at the close of business on the record date.
read full: http://finance.yahoo.com/news/intrexon-announces-distribution-ratio-distribution-120000752.html
*********************************************************
Tue, 02 Jun 2015 11:01:49 GMT ~ ZIOPHARM ONCOLOGY INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibit
read full: http://biz.yahoo.com/e/150602/ziop8-k.html
*********************************************************
Tue, 02 Jun 2015 11:00:00 GMT ~ ZIOPHARM Announces Caesar J. Belbel, Chief Legal Officer, Appointed Chief Operating Officer
[GlobeNewswire] - BOSTON -- ZIOPHARM Oncology, Inc. , a biopharmaceutical company focused on the development and commercialization of new cancer therapies, today announced that Caesar J. Belbel, Executive Vice President, ...
read full: http://finance.yahoo.com/news/ziopharm-announces-caesar-j-belbel-110000203.html
*********************************************************
$ZIOP charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$ZIOP company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/ZIOP/company-info
Ticker: $ZIOP
OTC Market Place: Not Available
CIK code: 0001107421
Company name: ZIOPHARM Oncology, Inc.
Company website: http://www.ziopharm.com
Incorporated In: DE, USA
$ZIOP share structure
## source: otcmarkets.com
Market Value: $221,106,456 a/o Jun 09, 2015
Shares Outstanding: 21,848,464 a/o Mar 12, 2009
Float: Not Available
Authorized Shares: Not Available
Par Value: No Par Value
$ZIOP extra dd links
Company name: ZIOPHARM Oncology, Inc.
Company website: http://www.ziopharm.com
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/ZIOP/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/ZIOP/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=ZIOP+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=ZIOP+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=ZIOP+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/ZIOP/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/ZIOP/news - http://finance.yahoo.com/q/h?s=ZIOP+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/ZIOP/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/ZIOP/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/ZIOP/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/ZIOP/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/ZIOP/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/ZIOP/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/ZIOP/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/ZIOP/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=ZIOP+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/ZIOP
DTCC (dtcc.com): http://search2.dtcc.com/?q=ZIOPHARM+Oncology%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=ZIOPHARM+Oncology%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=ZIOPHARM+Oncology%2C+Inc.&x=0&y=0
WHOIS (domaintools.com): http://whois.domaintools.com/http://www.ziopharm.com
Alexa (alexa.com): http://www.alexa.com/siteinfo/http://www.ziopharm.com#
Corporate website internet archive (archive.org): http://web.archive.org/web/*/http://www.ziopharm.com
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/ZIOP/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/ZIOP
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/ZIOP/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/ZIOP/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/ZIOP/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001107421&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/ZIOP/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/ZIOP/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/ZIOP/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/ZIOP/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=ZIOP&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=ZIOP
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/ZIOP/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=ZIOP+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=ZIOP+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=ZIOP
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=ZIOP
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=ZIOP+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/ZIOP/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=ZIOP+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/ZIOP.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=ZIOP
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/ZIOP/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/ZIOP/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/ZIOP/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/ZIOP/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/ZIOP
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/ZIOP
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/ZIOP:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=ZIOP
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=ZIOP
$ZIOP DD Notes ~ http://www.ddnotesmaker.com/ZIOP
Form 4 filed for distribution of the dividend as well for XON. Now we may begin to hear some news pertaining to ZIOP itself.
Form 4 filed for distribution of the dividend as well for XON. Now we may begin to hear some news pertaining to ZIOP itself.
Lol I heard that..no problem bud
Thanks. Since I started night shift I'm lost when it comes to the date, haha.
Should have bought more, I told you :p
When is the 12th?
Is the record date was the 4th with shares delivered on the 12th.
Weeeeeeee,,, lol
Maybe XON shorts buying ZIOP for tomorrow's dividend.
les forget about it and come back check after a month, lol ~ ZIOP
No but I forgot his name.
good day today!! but then again gotta be careful as biotech has been volatile recently.
Hi buckii, was this a response to growacet?
i see the message was deleted. Haha
I was here in March when the PPS was $13/$14....
And yes, the pumping shills told everyone to ignore me....and no doubt some pour souls did, and watched ZIOP tank under $10 for big losses.
Don't like what I have to say? Put me on iggy then, no skin for me. And if you're one of the P&D crowd then you can argue till your blue for all I care. Check the MOBI board back in the fall when it was $10+....I got the same treatment there.
Followers
|
83
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
1231
|
Created
|
08/08/06
|
Type
|
Free
|
Moderators |
http://www.ziopharm.com/
http://finance.yahoo.com/q/h?s=ZIOP
ZIOPHARM Oncology, Inc., a biopharmaceutical company, engages in the development and commercialization of a portfolio of in-licensed cancer drugs. It focuses primarily on the licensing and development of proprietary drug candidate families that are related to cancer therapeutics that are already on the market or in development. The company�s product candidates include ZIO-101, ZIO-201, and ZIO-301, which are in phase I and/or II studies. ZIO-101, organic arsenic is in a phase I/II trial in patients with advanced myeloma, as well as a phase I trial in advanced cancers; ZIO-201, stabilized isophosphoramide mustard is in a phase I/II trial in patients with advanced sarcoma, as well as in a phase I trials in advanced cancers; and ZIO-301, an anti-cancer agent that targets mitosis like the taxanes is in a phase I trial. ZIOPHARM was founded in 2003 and is based in New York, New York.
>
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |